Dynamics of vitamin K antagonist and new oral anticoagulants use in atrial fibrillation: a Danish drug utilization study-Reference-Cited by-同舟云学术

Dynamics of vitamin K antagonist and new oral anticoagulants use in atrial fibrillation: a Danish drug utilization study

Published:2014-08-11 Issue:9 Volume:12 Page:1413-1418
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Pottegård A.¹²^ORCID,Poulsen B. K.³,Larsen M. D.⁴,Hallas J.¹²

Affiliation:

1. Clinical Pharmacology; Institute of Public Health; University of Southern Denmark; Odense Denmark

2. Department of Clinical Chemistry & Pharmacology; Odense University Hospital; Odense Denmark

3. Department of Clinical Pharmacology; University Hospital of Aarhus; Aarhus Denmark

4. Clinical Epidemiology; Odense University Hospital; Odense Denmark

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12662/fullpdf

Reference17 articles.

1. American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Ansell;Chest,2008

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Study Investigators. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study;ROCKET AF Study Investigators;Am Heart J,2010

4. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

5. American College of Chest Physicians. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;You;Chest,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral anticoagulant switching in patients with atrial fibrillation: a scoping review;BMJ Open;2023-04

2. Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study;Research and Practice in Thrombosis and Haemostasis;2019-10-24

3. Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study;Thrombosis and Haemostasis;2019-03-21

4. Uptake of Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in a Single Clinical Commissioning Group in England Without Restrictions to Their Use;Clinical Drug Investigation;2019-02-25

5. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry;International Journal of Cardiology;2018-11